Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(15 sites)
United States
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California Los Angeles General Medical Center, Los Angeles, California USC / Norris Comprehensive Cancer Center, Los Angeles, California UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California UCHealth University of Colorado Hospital, Aurora, Colorado University of Kansas Clinical Research Center, Fairway, Kansas University of Kansas Cancer Center, Kansas City, Kansas University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas Ochsner Medical Center Jefferson, New Orleans, Louisiana Ohio State University Comprehensive Cancer Center, Columbus, Ohio University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma M D Anderson Cancer Center, Houston, Texas University of Virginia Cancer Center, Charlottesville, Virginia VCU Massey Comprehensive Cancer Center, Richmond, Virginia